179 related articles for article (PubMed ID: 20948709)
1. Radioiodine treatment for non-toxic goitre.
Feldt-Rasmussen U
F1000 Med Rep; 2009 Sep; 1():. PubMed ID: 20948709
[TBL] [Abstract][Full Text] [Related]
2. Recombinant human thyrotropin (rhTSH)-aided radioiodine treatment for non-toxic multinodular goitre.
Huo Y; Xie J; Chen S; Wang H; Ma C
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD010622. PubMed ID: 34961921
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human thyrotropin stimulation prior to
Azorín Belda MJ; Martínez Caballero A; Figueroa Ardila GC; Martínez Ramírez M; Gómez Jaramillo CA; Dolado Ardit JI; Verdú Rico J
Rev Esp Med Nucl Imagen Mol; 2017; 36(1):7-12. PubMed ID: 27422154
[TBL] [Abstract][Full Text] [Related]
4. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH).
Bonnema SJ; Nielsen VE; Hegedüs L
Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838
[TBL] [Abstract][Full Text] [Related]
5. Time to reconsider nonsurgical therapy of benign non-toxic multinodular goitre: focus on recombinant human TSH augmented radioiodine therapy.
Fast S; Nielsen VE; Bonnema SJ; Hegedüs L
Eur J Endocrinol; 2009 Apr; 160(4):517-28. PubMed ID: 19106244
[TBL] [Abstract][Full Text] [Related]
6. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres.
Silva MN; Rubió IG; Romão R; Gebrin EM; Buchpiguel C; Tomimori E; Camargo R; Cardia MS; Medeiros-Neto G
Clin Endocrinol (Oxf); 2004 Mar; 60(3):300-8. PubMed ID: 15008994
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human thyrotropin before (131)I therapy in patients with nodular goitre: a meta-analysis of randomized controlled trials.
Lee YY; Tam KW; Lin YM; Leu WJ; Chang JC; Hsiao CL; Hsu MT; Hsieh AT
Clin Endocrinol (Oxf); 2015 Nov; 83(5):702-10. PubMed ID: 25370124
[TBL] [Abstract][Full Text] [Related]
8. The role of radioiodine therapy in benign nodular goitre.
Bonnema SJ; Fast S; Hegedüs L
Best Pract Res Clin Endocrinol Metab; 2014 Aug; 28(4):619-31. PubMed ID: 25047210
[TBL] [Abstract][Full Text] [Related]
9. Radioiodine therapy of benign non-toxic goitre. Potential role of recombinant human TSH.
Fast S; Bonnema SJ; Hegedüs L
Ann Endocrinol (Paris); 2011 Apr; 72(2):129-35. PubMed ID: 21513911
[TBL] [Abstract][Full Text] [Related]
10. Role of recombinant human TSH in the management of large euthyroid multinodular goitre: a new therapeutic option? Pros and cons.
Ceccarelli C; Brozzi F; Bianchi F; Santini P
Minerva Endocrinol; 2010 Sep; 35(3):161-71. PubMed ID: 20938419
[TBL] [Abstract][Full Text] [Related]
11. Recombinant human TSH increases the efficacy of a fixed activity of radioiodine for treatment of multinodular goitre.
Cubas ER; Paz-Filho GJ; Olandoski M; Goedert CA; Woellner LC; Carvalho GA; Graf H
Int J Clin Pract; 2009 Apr; 63(4):583-90. PubMed ID: 18803554
[TBL] [Abstract][Full Text] [Related]
12. Significance of radioiodine uptake at 72 hours versus 24 hours after pretreatment with recombinant human thyrotropin for enhancement of radioiodine therapy in patients with symptomatic nontoxic or toxic multinodular goiter.
Duick DS; Baskin HJ
Endocr Pract; 2004; 10(3):253-60. PubMed ID: 15310544
[TBL] [Abstract][Full Text] [Related]
13. Radioiodine treatment of thyroid cancer with the aid of recombinant human thyrotropin.
Adler ML; Macapinlac HA; Robbins RJ
Endocr Pract; 1998; 4(5):282-6. PubMed ID: 15251726
[TBL] [Abstract][Full Text] [Related]
14. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
[TBL] [Abstract][Full Text] [Related]
15. [Therapy for non-toxic multinodular goiter: radioiodine therapy as attractive alternative to surgery].
Dietlein M; Dederichs B; Kobe C; Theissen P; Schmidt M; Schicha H
Nuklearmedizin; 2006; 45(1):21-34; quiz N1-2. PubMed ID: 16493511
[TBL] [Abstract][Full Text] [Related]
16. Dosimetry of radioiodine therapy in patients with nodular goiter after pretreatment with a single, low dose of recombinant human thyroid-stimulating hormone.
Nieuwlaat WA; Hermus AR; Ross HA; Buijs WC; Edelbroek MA; Bus JW; Corstens FH; Huysmans DA
J Nucl Med; 2004 Apr; 45(4):626-33. PubMed ID: 15073259
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment with recombinant human TSH changes the regional distribution of radioiodine on thyroid scintigrams of nodular goiters.
Nieuwlaat WA; Hermus AR; Sivro-Prndelj F; Corstens FH; Huysmans DA
J Clin Endocrinol Metab; 2001 Nov; 86(11):5330-6. PubMed ID: 11701700
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of various doses of recombinant human thyrotropin in patients with multinodular goiters.
Braverman L; Kloos RT; Law B; Kipnes M; Dionne M; Magner J
Endocr Pract; 2008 Oct; 14(7):832-9. PubMed ID: 18996810
[TBL] [Abstract][Full Text] [Related]
19. A 30-year perspective on radioiodine therapy of benign nontoxic multinodular goiter.
Bonnema SJ; Hegedüs L
Curr Opin Endocrinol Diabetes Obes; 2009 Oct; 16(5):379-84. PubMed ID: 19623060
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome after radioiodine therapy with adjuvant rhTSH treatment: comparison between patients with non-toxic and pre-toxic large multinodular goitre.
Giusti M; Caorsi V; Mortara L; Caputo M; Monti E; Schiavo M; Bagnara MC; Minuto F; Bagnasco M
Endocrine; 2014 Mar; 45(2):221-9. PubMed ID: 23619962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
